KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 60 filers reported holding KINNATE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.76 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,743 | -53.8% | 61,959 | 0.0% | 0.00% | – |
| Q2 2023 | $187,736 | -93.6% | 61,959 | -86.7% | 0.00% | – |
| Q1 2023 | $2,914,881 | -48.4% | 466,381 | -49.7% | 0.00% | – |
| Q4 2022 | $5,650,820 | +1.4% | 926,364 | +98.6% | 0.00% | – |
| Q3 2022 | $5,575,000 | -2.2% | 466,521 | +3.1% | 0.00% | – |
| Q2 2022 | $5,703,000 | +19.7% | 452,278 | +6.9% | 0.00% | – |
| Q1 2022 | $4,765,000 | -30.9% | 423,154 | +8.8% | 0.00% | – |
| Q4 2021 | $6,892,000 | -10.0% | 388,930 | +16.9% | 0.00% | – |
| Q3 2021 | $7,656,000 | +38.7% | 332,575 | +40.3% | 0.00% | – |
| Q2 2021 | $5,520,000 | -3.3% | 237,130 | +29.4% | 0.00% | – |
| Q1 2021 | $5,711,000 | – | 183,282 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $60,447,769 | 31.36% |
| Vida Ventures Advisors, LLC | 2,207,772 | $13,798,575 | 18.88% |
| Lynx1 Capital Management LP | 2,214,250 | $13,839,063 | 11.54% |
| Foresite Capital Management V, LLC | 1,975,001 | $12,343,756 | 9.12% |
| Nextech Invest Ltd. | 2,329,480 | $14,559,250 | 6.08% |
| Ally Bridge Group (NY) LLC | 109,393 | $683,706 | 0.90% |
| Orbimed Advisors | 5,143,629 | $32,147,681 | 0.63% |
| RA Capital Management | 4,264,144 | $26,650,900 | 0.60% |
| Novo Holdings A/S | 815,707 | $5,098,169 | 0.34% |
| HARVARD MANAGEMENT CO INC | 498,001 | $3,112,506 | 0.33% |